Grace Therapeutics, Inc. (GRCE)
$2.02-2.88%Close
SELLRECOVERY · day 41
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $33M
- Beta
- 0.37
- P/E (TTM)
- -1.64
- Short % float
- 12.66%
- Days to cover
- 19.0
- SI change
- -2.5%
- 1W
- -1.94%
- 1M
- -9.01%
- vs SPY 1W
- -2.36%
- vs SPY 1M
- -11.07%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GRCE?
- LOPJLB’s latest quantitative signal on Grace Therapeutics, Inc. (GRCE) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is GRCE in?
- Grace Therapeutics, Inc. (GRCE) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Grace Therapeutics, Inc. (GRCE) do?
- Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betame…